- Palliative Pharmacotherapy Guideline for Pharmacists
- SOALAN-SOALAN LAZIM (FAQ) BERKAITAN TUNTUTAN MATA CPD PROGRAM PERKHIDMATAN FARMASI
- Siri Panduan Infografik Berkaitan Tuntutan Mata CPD
- Permohonan Pendaftaran Sementara Ahli Farmasi dengan Lembaga Farmasi Malaysia
- Pesanan Untuk Ahli Farmasi Berdaftar
Anda di sini
Formulari Ubat KKM (FUKKM)
| # | Generic Name | MDC | Category | Indications | Pres. Restrictions | Dosage |
|---|---|---|---|---|---|---|
| 1681 | Zoledronic Acid 4 mg Injection | M05BA08000P3001XX | A* | i) Treatment of hypercalcaemia of malignancy ii) Prevention of skeletal related events (SREs) in patients with multiple myeloma involving multiple bone lesions iii) Prevention of skeletal related events (SREs) for metastatic cancers of solid tumours | i) 4mg single dose ii) 4mg every 3-4 weeks iii) 4mg reconstituted and should be given as a 15- minute IV infusion every 12 weeks (as advised in MaHTAS 2018 Report) | |
| 1682 | Zolpidem Tartrate 10 mg Tablet | N05CF02123T1001XX | A | For treatment of insomnia | ADULT: 10mg daily at bedtime ELDERLY OR DEBILITATED SUBJECTS: 5mg daily at bed time Max. dose: 10mg daily | |
| 1683 | Zonisamide 100mg tablet | N03AX15-000-T10-01-XXX | A* | As adjunctive therapy in the treatment of partial seizures in adults with epilepsy. | As adjunctive therapy in the treatment of partial seizures in adults with epilepsy when 1st line and 2nd line therapy failed. | For adults, usually 100 to 200mg of zonisomide is to be administered orally 1 to 3 times a day initially. The dose is gradually increased at every one to two weeks up to 200-400mg daily, in 1 to 3 divided dose. The maximum daily dose should not exceed 600mg per day. |
| 1684 | Zuclopenthixol 20 mg/ml Drops | N05AF05000D5001XX | A* | i) Acute schizophrenia and other acute psychoses, including agitation ii) Chronic schizophrenia and other chronic psychoses iii) Mania | i) & iii) 10-50mg daily Max. dose: 100-150mg daily in 2-3 divided doses ii) 20-40mg daily | |
| 1685 | Zuclopenthixol Acetate 50 mg/ml Injection | N05AF05122P3001XX | A* | Initial treatment of acute psychoses, including mania, and exacerbations of chronic psychoses in patients not responding to available standard drugs | 50-150mg IM repeated if necessary, preferably within a time interval of 2-3 days. Additional injection may be needed 24-48 hours following the first injection | |
| 1686 | Zuclopenthixol Decanoate 200 mg/ml Injection | N05AF05135P2001XX | B | Maintenance treatment of schizophrenia and other psychoses, especially with symptoms such as hallucinations, delusions and thought disturbances along with agitation, restlessness, hostility and aggressiveness in patients not responding to available standard drugs | By deep IM injection test dose 100 mg followed after 7 - 28 days by 100 - 200 mg or more followed by 200 - 400 mg at intervals of 2 - 4 weeks adjusted according to response. Maximum 600 mg weekly. Child not recommended |